Literature DB >> 14658436

Aptamares: a novel class of radiopharmaceutical with diagnostic and therapeutic potential.

S Guhlke, M Famulok, H J Biersack.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14658436     DOI： 10.1007/s00259-003-1346-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  13 in total

Review 1.  Antisense imaging: where are we now?

Authors:  D J Hnatowich
Journal:  Cancer Biother Radiopharm       Date:  2000-10       Impact factor: 3.099

Review 2.  Aptamers as tools in molecular biology and immunology.

Authors:  M Famulok; G Mayer
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

3.  Development of a lyophilized kit formulation for labeling of DNA probes with 99mTc.

Authors:  O K Hjelstuen; A M Saetern; H H Tonnesen; P O Bremer; A M Verbruggen
Journal:  Int J Pharm       Date:  1999-11-15       Impact factor: 5.875

4.  Escort aptamers: a delivery service for diagnosis and therapy.

Authors:  B J Hicke; A W Stephens
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

5.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

6.  General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies.

Authors:  B Kühnast; F Dollé; S Terrazzino; B Rousseau; C Loc'h; F Vaufrey; F Hinnen; I Doignon; F Pillon; C David; C Crouzel; B Tavitian
Journal:  Bioconjug Chem       Date:  2000 Sep-Oct       Impact factor: 4.774

7.  In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase.

Authors:  J Charlton; J Sennello; D Smith
Journal:  Chem Biol       Date:  1997-11

Review 8.  Small peptides radiolabeled with 99mTc.

Authors:  J Lister-James; B R Moyer; T Dean
Journal:  Q J Nucl Med       Date:  1996-09

9.  The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo.

Authors:  R J Buckanovich; R B Darnell
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

Review 10.  Aptamers as therapeutic and diagnostic agents.

Authors:  E N Brody; L Gold
Journal:  J Biotechnol       Date:  2000-03       Impact factor: 3.307
View more
  3 in total

1.  In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals.

Authors:  Raphaël Boisgard; Bertrand Kuhnast; Stefan Vonhoff; Chéraz Younes; Françoise Hinnen; Jean-Marc Verbavatz; Bernard Rousseau; Jens Peter Fürste; Britta Wlotzka; Frédéric Dollé; Sven Klussmann; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-22       Impact factor: 9.236

2.  In vivo molecular targeted radiotherapy.

Authors:  Ac Perkins
Journal:  Biomed Imaging Interv J       Date:  2005-10-01

3.  Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.

Authors:  Dongxi Xiang; Conglong Zheng; Shu-Feng Zhou; Shuxi Qiao; Phuong Ha-Lien Tran; Chunwen Pu; Yong Li; Lingxue Kong; Abbas Z Kouzani; Jia Lin; Ke Liu; Lianhong Li; Sarah Shigdar; Wei Duan
Journal:  Theranostics       Date:  2015-07-02       Impact factor: 11.556
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.